Helius Medical Technologies is trading at $2.97, up 7.61%, as broader risk-on conditions support growth-oriented equities.
- Shares are extending the September 18, 2026 rally, when they gained 20.52% to close at $2.76.
- No clear company-specific announcement dated September 21, 2026, has been identified.
- The S&P 500 rose 0.64%, Nasdaq gained 0.85%, and Dow advanced 0.52%, while falling oil prices and easing yields supported growth-oriented equities.